| Medigene AG. (5/5/17). "Press Release: Medigene Successfully Raises EUR 20.7 Million in Oversubscribed Private Placement [NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Planegg. |
2017-05-05 |
| Medigene AG. (5/4/17). "Press Release: Medigene Announces Capital Increase of New Shares [NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Planegg. |
2017-05-04 |
| Stratec Biomedical AG. (5/4/17). "Press Release: Stratec Continues Growth in 2017". Birkenfeld. |
2017-05-04 |
| MorphoSys AG. (5/3/17). "Press Release: MorphoSys AG Reports Solid First Quarter 2017". Planegg-Martinsried. |
2017-05-03 |
| Zedira GmbH. (5/2/17). "Press Release: Dr. Falk Pharma and Zedira Announce Completion of Phase 1b Clinical Trial of ZED1227 for the Treatment of Celiac Disease and Move on to Proof of Concept Study". Freiburg & Darmstadt. |
2017-05-02 |
| Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. |
2017-04-28 |
| Sygnis AG. (4/27/17). "Press Release: Sygnis AG Reports Financial Results for Fiscal Year 2016". Madrid & Heidelberg. |
2017-04-27 |
| Enamine Ltd.. (4/25/17). "Press Release: Enamine to Collaborate with EMBL for Cancer Drug Discovery Research". Kiev. |
2017-04-25 |
| Wilex AG. (4/24/17). "Press Release: Wilex AG Plans Rights Issue Using Authorised Capital. Ad-hoc release [Not for distribution, publication or transmission in the USA, Canada, Japan and Australia]". Munich. |
2017-04-24 |
| Sygnis AG. (4/24/17). "Press Release: Sygnis AG Expands Access to Chinese Market with Second OEM Deal with Tanon". Madrid & Heidelberg. |
2017-04-24 |
| Bruker Corporation. (4/21/17). "Press Release: Bruker Introduces New Clinical Microbiology Assays and Kits at ECCMID". Vienna. |
2017-04-21 |
| Curetis N.V.. (4/20/17). "Press Release: Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking". Amsterdam & Holzgerlingen. |
2017-04-20 |
| Wilex AG. (4/12/17). "Press Release: Interim Management Statement on the First Three Months of 2017". Munich. |
2017-04-12 |
| Intellia Therapeutics, Inc.. (4/11/17). "Press Release: Intellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent". Cambridge, MA. |
2017-04-11 |
| MorphoSys AG. (4/11/17). "Press Release: MorphoSys to Present at Upcoming Conferences". Planegg-Martinsried. |
2017-04-11 |
| Apogenix AG. (4/11/17). "Press Release: Apogenix Announces Initiation of Clinical Development for ABBV-621 to Treat Solid and Hematologic Tumors by Partner AbbVie". Heidelberg. |
2017-04-11 |
| Sygnis AG. (4/11/17). "Press Release: Sygnis AG Successfully Completes Integration of Recently Acquired C.B.S. Scientific". Madrid & Heidelberg. |
2017-04-11 |
| Numares AG. (4/4/17). "Press Release: Numares Announces Commercial Launch of renalTX-SCORE". Regensburg. |
2017-04-04 |
| MorphoSys AG. (4/3/17). "Press Release: MorphoSys Nominates New Candidate for Supervisory Board". Planegg-Martinsried. |
2017-04-03 |
| Advion, Inc.. (4/3/17). "Press Release: Advion’s New Inert Probe Allows Real Time Reaction Monitoring of Air Sensitive Compounds". Ithaca, NY. |
2017-04-03 |
| LGC Ltd.. (4/3/17). "Press Release: LGC Acquires Axolabs and Invests in GMP Manufacturing Capacity for Therapeutic Nucleic Acids". |
2017-04-03 |
| Medigene AG. (3/28/17). "Press Release: Medigene Announces Participation at Six National and International Conferences". Planegg. |
2017-03-28 |
| Bruker Corporation. (3/27/17). "Press Release: Bruker Introduces Novel NMR Solutions at ENC 2017". Asilomar, CA. |
2017-03-27 |
| Immatics Biotechnologies GmbH. (3/24/17). "Press Release: EU-funded Consortium Led by Immatics and BioNTech Announces Completion of Regular Study Treatment in the GAPVAC-101 Trial". Tübingen. |
2017-03-24 |
| Medigene AG. (3/23/17). "Press Release: Announces Target and Outlines Design for Its First Clinical Trial in TCR Cancer Immunotherapy". Planegg-Martinsried. |
2017-03-23 |
| Medigene AG. (3/23/17). "Press Release: Medigene Publishes Its 2016 Annual Report and Outlook for 2017". Martinsried. |
2017-03-23 |
| MorphoSys AG. (3/23/17). "Press Release: MorphoSys’s CSO Marlies Sproll Takes Temporary Leave. Markus Enzelberger to Serve as Interim CSO". Planegg-Martinsried. |
2017-03-23 |
| Numares AG. (3/23/17). "Press Release: Numares AG and Oxford University to Collaborate on Development of Multiple Sclerosis Diagnostic Test". Regensburg & Oxford. |
2017-03-23 |
| Affimed N.V.. (3/14/17). "Press Release: Affimed to Present at the Oppenheimer 27th Annual Healthcare Conference – New York". Heidelberg. |
2017-03-14 |
| Bruker Corporation. (3/14/17). "Press Release: Data-safe Process & Quality Control of APIs and Inorganic Impurities with Bruker´s EDXRF Spectrometer S2 PUMA". |
2017-03-14 |
| Definiens AG. (3/13/17). "Press Release: NeoGenomics and Definiens Enter into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing". Fort Myers, FL. |
2017-03-13 |
| MorphoSys AG. (3/9/17). "Press Release: MorphoSys AG Presents Strong Results for Fiscal Year 2016". Planegg-Martinsried. |
2017-03-09 |
| MorphoSys AG. (3/6/17). "Press Release: MorphoSys Partner to Start New Phase 3 Clinical Trials with Gantenerumab in Alzheimer’s Disease". Planegg-Martinsried. |
2017-03-06 |
| Novartis AG. (3/6/17). "Press Release: New Data Demonstrate Sandoz Proposed Biosimilar Adalimumab Has Equivalent Efficacy to Reference Medicine". Holzkirchen. |
2017-03-06 |
| MorphoSys AG. (3/3/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Reported New Data From Two Phase 3 Studies of Guselkumab in Plaque Psoriasis". Planegg. |
2017-03-03 |
| Bruker Corporation. (3/3/17). "Press Release: Alcami Invests in Bruker’s D8 Discover HTS System for High-Throughput X-Ray Diffraction Screening in Pharmaceutical Formulation Development". Weert & Karlsruhe. |
2017-03-03 |
| Affimed N.V.. (3/1/17). "Press Release: Affimed to Present Data on Immune Cell Engagers at the AACR Annual Meeting 2017". Heidelberg. |
2017-03-01 |
| Sygnis AG. (3/1/17). "Press Release: Sygnis AG Announces Management Changes. David Roth Appointed Chief Financial Officer (CFO)
". Madrid & Heidelberg. |
2017-03-01 |
| InfanDx AG. (3/1/17). "Press Release: InfanDx AG Wins New Investor and Prepares for Round B Financing". Cologne & Bonn. |
2017-03-01 |
| Affimed N.V.. (2/28/17). "Press Release: Affimed to Present at the Cowen and Company 37th Annual Health Care Conference". Heidelberg. |
2017-02-28 |
| Neovacs S.A.. (2/21/17). "Press Release: Neovacs and BioSense Sign Option Agreement Worth up to €65 Million plus Royalties for Chinese Development and Commercial Rights to IFNalpha Kinoid for Lupus and Dermatomyositis". Paris. |
2017-02-21 |
| MorphoSys AG. (2/21/17). "Press Release: MorphoSys’s Subsidiary Lanthio Pharma Initiates First-in-Human Clinical Study with Lanthipeptide MOR107". Planegg. |
2017-02-21 |
| CellGenix GmbH. (2/21/17). "Press Release: CellGenix Headquarters Expands to Meet the Increasing Demands for GMP Cell Culture Reagents". Freiburg. |
2017-02-21 |
| ActeaVentures GmbH. (2/21/17). "Press Release: ActeaVentures Successfully Assisted Neovacs in Partnering IFN-K for Lupus to BioSense Global for the Chinese Market". Karlsruhe. |
2017-02-21 |
| Sartorius AG. (2/17/16). "Press Release: Sartorius Enters Into a Corporate Partnership Program with the European Molecular Biology Laboratory (EMBL)". Göttingen. |
2017-02-17 |
| MorphoSys AG. (2/15/17). "Press Release: District Court Grants MorphoSys's Request to Add Second Patent in Lawsuit with Janssen Biotech and Genmab". Planegg. |
2017-02-15 |
| BioNTech AG. (2/15/17). "Press Release: MammaTyper Enables More Precise Prediction of the Response to Neoadjuvent Chemotherapy Compared to Manual or Digitalized IHC". Mainz. |
2017-02-15 |
| MIG Verwaltungs AG. (2/13/17). "Pressemitteilung: MIG veräußert Aktienpaket an BRAIN AG". München. |
2017-02-13 |
| MorphoSys AG. (2/10/17). "Press Release: MorphoSys to Present at Upcoming Conference". Planegg. |
2017-02-10 |
| Affimed N.V.. (2/8/17). "Press Release: Affimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference". Heidelberg. |
2017-02-08 |
| Global Bioenergies S.A.. (2/7/17). "Press Release: First Production in History of Fully Renewable ETBE". Évry. |
2017-02-07 |
| Numares AG. (2/7/167). "Press Release: Numares Initiates Worldwide Commercial Launch of insightLPTM-S50 to Provide New Insights in Lipoprotein Research". Regensburg. |
2017-02-07 |
| Atriva Therapeutics GmbH. (2/7/17). "Press Release: Atriva Receives Seed Financing to Develop Its Next Generation Influenza Therapeutic". Tübingen. |
2017-02-07 |
| Atriva Therapeutics GmbH. (2/7/17). "Press Release: Atriva Reaches a Development Milestone and Receives an Additional Tranche of Running Seed Financing to Develop Its Influenza Therapeutic to Clinical Stage". Tübingen. |
2017-02-07 |
| Genedata AG. (2/6/17). "Press Release: SLAS2017 – Genedata Announces BMG LABTECH, Creoptix and TTP Labtech as New Ready-to-Run Partners". Washington, DC. |
2017-02-06 |
| Wilex AG. (2/6/17). "Press Release: Wilex AG Secures Financing Commitment from Its Main Shareholder Dievini". Munich. |
2017-02-06 |
| 4SC AG. (2/6/17). "Press Release: 4SC AG to Present at the 19th Annual BIO CEO & Investor Conference 2017". Planegg-Martinsried. |
2017-02-06 |
| UV-Cap GmbH & Co. KG. (2/3/17). "Press Release: UV-Cap GmbH & Co KG Acquires Scil Proteins GmbH. Scil Proteins GmbH Becomes Navigo Proteins GmbH". Halle (Saale). |
2017-02-03 |
| Medigene AG. (2/2/17). "Press Release: Medigene Participates at Five National and International Conferences in February and March 2017". Martinsried. |
2017-02-02 |
| Sygnis AG. (2/2/17). "Press Release: Sygnis AG Announces the Launch of TrueHelix". Madrid & Heidelberg. |
2017-02-02 |
| Rentschler Biotechnologie GmbH. (2/2/17). "Press Release: Rentschler and Leukocare Announce Strategic Alliance And Equity Investment". Laupheim & Martinsried. |
2017-02-02 |
| Genedata AG. (2/1/17). "Press Release: New Genedata Screener APC Functionality and Integration with Nanion SyncroPatch 384PE at SLAS2017". Basel & Munich. |
2017-02-01 |
| Immunic AG. (2/1/17). "Press Release: Immunic Adds EUR 4 Million in Funding to Further Boost Development. Series A Financing Round Extended to EUR 21.7 Million". Planegg-Martinsried & Magdeburg. |
2017-02-01 |
| Stolmár & Partner Patentanwälte. (1/31/17). "Press Release: Stolmár & Partners Is Excited to Welcome Dr. Leopold Gruner in Our Life Science Team". |
2017-01-31 |
| Technische Universität München. (1/30/17). "Press Release: ProteomeTools – Synthetic Peptides and Spectra for Proteomics.
Milestone for the Analysis of Human Proteomes". |
2017-01-30 |
| Wilex AG. (1/25/17). "Press Release: Subsidiary Heidelberg Pharma Exercises Option on BCMA Antibodies of the Max Delbrück Center and Signs License Agreement". Munich. |
2017-01-25 |
| Affimed N.V.. (1/25/17). "Press Release: Affimed Announces Closing of Public Offering of Common Stock". Heidelberg. |
2017-01-25 |
| AMSilk GmbH. (1/20/17). "Press Release: An Innovative High-performance Material – Biofibers Made from Green Lacewing Silk". |
2017-01-20 |
| Affimed N.V.. (1/20/17). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. |
2017-01-20 |
| CureVac AG. (1/20/17). "Press Release: CureVac’s CEO, Ingmar Hoerr, Appointed by European Commission to High Level Group". Tübingen. |
2017-01-20 |
| Affimed N.V.. (1/19/17). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. |
2017-01-19 |
| Protagen AG. (1/17/17). "Press Release: The German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Investigate Responsiveness to Checkpoint Inhibitors in Melanoma". |
2017-01-17 |
| MorphoSys AG. (1/12/17). "Press Release: MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes". Planegg. |
2017-01-12 |
| Luxendo GmbH. (1/12/17). "Press Release: Luxendo Announces Series A Extension Bringing Total Capital Raised to €8 Million". Heidelberg. |
2017-01-12 |
| CureVac AG. (1/11/17). "Press Release: CureVac Provides Clinical Update at 35th Annual J.P. Morgan Healthcare Conference". San Francisco, CA & Tübingen. |
2017-01-11 |
| Affimed N.V.. (1/11/17). "Press Release: Affimed Provides Update on NK-Cell Immuno-Oncology Platform". Heidelberg. |
2017-01-11 |
| Immunic AG. (1/9/17). "Press Release: Immunic Strengthens Management Team and Supervisory Board". Planegg-Martinsried. |
2017-01-09 |
| Immatics Biotechnologies GmbH. (1/9/17). "Press Release: Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies". Thousand Oaks, CA & Tübingen. |
2017-01-09 |
| HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen. |
2017-01-05 |
| Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. |
2017-01-05 |
| MorphoSys AG. (1/5/17). "Press Release: Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG". Planegg. |
2017-01-05 |
| Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. |
2017-01-04 |
| MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. |
2017-01-03 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
